Rafael Antonio Burgos-Calderon Investigator

Nephrology NPI1376653162

Open Payments

Note

The following payment details are based on a national transparency program known as the Sunshine Act that collects and publishes information about financial relationships between the health care industry (i.e. drug and device manufactures) and providers. These relationships may involve payment to providers for things such as research, speaking engagment, travel, gifts etc. Not all of these payment involve monetary compensations and may include batering of drugs or devices.

Total Payment Worth

$17,118.87
from 37 payments in the last 6 years

Total Cash or Cash Equivalent

$8,879.20
from 8 payments in the last 6 years

Total In-kind Items & Services

$8,239.67
from 29 payments in the last 6 years

Nature of Payments

Last 6 Years
Chart will render here...

Yearly Breakdown

Chart will render here...

Payment Details

Date Payment Type Form of Payment Item/Service Payment Amount
12/07/2021 General (Non-Research) In-kind items and services Education $95.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 830282423
09/07/2021 General (Non-Research) In-kind items and services Food and Beverage $14.95 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 829855807
12/08/2021 General (Non-Research) In-kind items and services Food and Beverage $125.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 829756693
09/24/2021 General (Non-Research) In-kind items and services Food and Beverage $17.00 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 829375991
02/05/2021 Research In-kind items and services $150.57 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK
Clinical Trials Gov ID NCT03730662
Payment Record ID 819445509
09/10/2021 General (Non-Research) In-kind items and services Food and Beverage $20.72 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Payment Record ID 789160433
10/29/2021 General (Non-Research) In-kind items and services Food and Beverage $17.84 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Payment Record ID 789105139
10/22/2021 General (Non-Research) In-kind items and services Food and Beverage $12.68 Details
Payment from Bayer HealthCare Pharmaceuticals Inc.
Payment Record ID 789051435
12/13/2021 General (Non-Research) In-kind items and services Food and Beverage $26.76 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 788171655
08/13/2021 General (Non-Research) In-kind items and services Food and Beverage $20.28 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 788171653
06/14/2021 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1000.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 788171651
01/16/2020 Research In-kind items and services $1726.55 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK
Clinical Trials Gov ID NCT03730662
Payment Record ID 728722433
03/20/2020 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $3770.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719360171
03/09/2020 General (Non-Research) In-kind items and services Food and Beverage $80.25 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719360169
11/04/2020 General (Non-Research) Cash or cash equivalent Consulting Fee $375.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719360167
06/01/2020 General (Non-Research) Cash or cash equivalent Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1000.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 719360165
02/28/2019 General (Non-Research) In-kind items and services Food and Beverage $21.95 Details
Payment from Allergan Inc.
Payment Record ID 670156539
12/13/2019 General (Non-Research) In-kind items and services Food and Beverage $106.37 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377411
12/13/2019 General (Non-Research) In-kind items and services Travel and Lodging $21.66 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377407
12/13/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $2340.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377403
11/13/2019 General (Non-Research) Cash or cash equivalent Consulting Fee $375.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377399
09/19/2019 General (Non-Research) In-kind items and services Food and Beverage $100.00 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377395
08/14/2019 General (Non-Research) In-kind items and services Food and Beverage $17.04 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377391
06/26/2019 General (Non-Research) In-kind items and services Food and Beverage $17.74 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377387
06/18/2019 General (Non-Research) In-kind items and services Education $5.26 Details
Payment from Janssen Pharmaceuticals, Inc
Payment Record ID 658377381
04/08/2019 Research In-kind items and services $2778.33 Details
Payment from Eli Lilly and Company
Paymment Research Study A STUDY OF TIRZEPATIDE (LY3298176) ONCE A WEEK VERSUS INSULIN GLARGINE ONCE A DAY IN PARTICIPANTS WITH TYPE 2 DIABETES AND INCREASED CARDIOVASCULAR RISK
Clinical Trials Gov ID NCT03730662
Payment Record ID 654283529
12/17/2018 General (Non-Research) Cash or cash equivalent Food and Beverage $17.69 Details
Payment from Eli Lilly and Company
Payment Record ID 559629555
11/30/2018 General (Non-Research) In-kind items and services Travel and Lodging $431.98 Details
Payment from Eli Lilly and Company
Payment Record ID 559629553
11/30/2018 General (Non-Research) In-kind items and services Travel and Lodging $280.00 Details
Payment from Eli Lilly and Company
Payment Record ID 559629551
11/30/2018 General (Non-Research) In-kind items and services Food and Beverage $360.02 Details
Payment from Eli Lilly and Company
Payment Record ID 559629549
11/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $634.20 Details
Payment from Eli Lilly and Company
Payment Record ID 559629547
11/29/2018 General (Non-Research) In-kind items and services Travel and Lodging $881.16 Details
Payment from Eli Lilly and Company
Payment Record ID 559629545
04/03/2017 General (Non-Research) In-kind items and services Food and Beverage $20.00 Details
Payment from Merck Sharp & Dohme Corporation
Payment Record ID 503731947
04/27/2016 Research In-kind items and services $99.76 Details
Payment from AbbVie, Inc.
Payment Record ID 395389442
03/02/2016 General (Non-Research) In-kind items and services Food and Beverage $98.38 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 362418240
08/29/2016 General (Non-Research) In-kind items and services Food and Beverage $58.22 Details
Payment from AstraZeneca Pharmaceuticals LP
Payment Record ID 362345820
03/09/2016 General (Non-Research) Cash or cash equivalent Food and Beverage $1.51 Details
Payment from ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
Payment Record ID 350869474